Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Merck presents amine derivatives with PDE5-inhibitory effects

May 21, 2001

Preparation and therapeutic uses of new alpha1A-adrenoceptor antagonists disclosed by Synaptic

May 18, 2001

EMD-221963, a representative NHE-3 inhibitor from Merck KGaA

May 17, 2001

NDA filed in Hong Kong for NexMed's ED treatment

May 16, 2001

Tanabe Seiyaku issued patent covering new PDE5 inhibitors and their use

May 11, 2001

Watson seeks FDA approval for overactive bladder treatment

May 4, 2001

Kissei and Daiichi will codevelop and comarket BPH Rx in Japan

May 3, 2001

Cialis demonstrates extended duration in clinical trials in ED

May 3, 2001

Tolterodine ER shows improved efficacy and safety

May 2, 2001

Senetek's Invicorp well tolerated for ED in hypertensive patients

April 25, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Selection Therapeutics identifies new Kv1.3 blockers
BioWorld Science
Selection Therapeutics GmbH has discovered new potassium voltage-gated channel subfamily A member 3 (KCNA3; Kv1.3) blockers potentially useful for the treatment...
Ignis Therapeutics synthesizes new muscarinic M4 receptor PAMs
BioWorld Science
Ignis Therapeutics (Suzhou) Co. Ltd. has patented new muscarinic M4 receptor positive allosteric modulators (PAMs) potentially useful for the treatment of...